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Abstract 
Stroke can affect females very differently from males, and therefore preclinical research on 
underlying mechanisms and the effects of interventions should not be restricted to male subjects, 
and treatment strategies for stroke should be tailored to benefit both sexes. Previously, we 
demonstrated that a multinutrient intervention (Fortasyn) improved impairments after ischemic 
stroke induction in male C57Bl/6 mice, but the therapeutic potential of this dietary treatment 
remained to be investigated in females. We now induced a transient middle cerebral artery 
occlusion (tMCAo) in C57Bl/6 female mice and immediately after surgery switched to either Fortasyn 
or an isocaloric Control diet. The stroke females performed several behavioral and motor tasks 
before and after tMCAo and were scanned in an 11.7 Tesla MRI scanner to assess brain perfusion, 
integrity and functional connectivity. To assess brain plasticity, inflammation and vascular integrity, 
immunohistochemistry was performed after sacrifice of the mice. We found that the multinutrient 
intervention had diverse effects on the stroke-induced impairments in females. Similar to previous 
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observations in male stroke mice, brain integrity, sensorimotor integration and neurogenesis 
benefitted from Fortasyn, but impairments in activity and motor skills were not improved in female 
stroke mice. Overall, Fortasyn effects in the stroked females seem more modest in comparison to 
previously investigated stroked male mice. We suggest that with further optimization of treatment 
protocols more information on the efficacy of specific interventions in stroked females can be 
gathered. This in turn will help with the development of (gender-specific) treatment regimens for 
cerebrovascular diseases such as stroke. 
 
Introduction 
Ischemic stroke is the most common type of stroke, accounting for 87% of all strokes (Mozaffarian et 
al. 2016). It may lead to brain lesions with an irreversibly injured core and a peripheral zone 
(penumbra) containing damaged but potentially salvageable tissue (Astrup et al. 1981). Acute 
symptoms of ischemic stroke can be facial weakness, hemiparesis, hemianopsia, and speech 
difficulties (Hankey & Blacker 2015), depending on the occluded artery. While patients can (partially) 
recover from some of these symptoms, demonstrating the capacity of the brain for repair and 
compensation after injury (Zeiler & Krakauer 2013), up to 40% of stroke patients remain physically 
disabled (Luengo-Fernandez et al. 2013). Ischemic stroke can also result in cognitive and behavioral 
deficits, as demonstrated by the propensity of stroke patients to develop Alzheimer’s disease (AD) 
(Kalaria 2000). Rather than being the result of damage at the site of the stroke lesion, these 
cognitive and behavioral deficits seem to be caused by lesions to brain networks (Siegel et al. 2016). 
All of these severe long-term consequences of stroke emphasize the need for effective treatment 
strategies. Currently, ischemic stroke treatment is mainly aimed at restoring blood flow by 
thrombolysis (e.g. treatment with tissue plasminogen activator) or thrombectomy and treating 
motor impairments (Hankey 2017). However, these treatment strategies only have a small 
therapeutic window to be effective (Lyden 2008) and do not improve the cognitive and behavioral 
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deficits induced by stroke. Therefore novel treatment strategies, that address both the stroke lesion 
and affected brain networks, need to be developed.  
 The food we consume can greatly affect our health. For example, adhering to a so-called 
Western diet, consisting of large amounts of saturated fatty acids, increases the risk to develop 
stroke (Foroughi et al. 2013) and AD (Hooijmans & Kiliaan 2008). On the other hand, consuming a 
Mediterranean diet containing, among other things, relatively high amounts of fish, nuts and olive oil 
is considered beneficial (Scarmeas et al. 2006). As shown in several large double-blind controlled 
studies like PREDIMED (Estruch et al. 2013) and the Northern Manhattan study (Gardener et al. 
2011), intake of a Mediterranean diet lowers the risk of vascular events such as stroke. Therefore, a 
diet containing components of the Mediterranean diet such as unsaturated fatty acids, vitamins and 
polyphenols, may be a valid approach for the prevention and treatment of vascular diseases. A 
specific multinutrient intervention (Fortasyn) was developed as a therapeutic intervention for early 
stage AD (van Wijk et al. 2014). It consists of several different dietary components facilitating 
neuronal membrane formation, including fatty acids, phospholipids and vitamins. Indeed, this diet 
has been shown to protect mouse models with AD-like pathology from neuronal degeneration 
(Wiesmann et al. 2016, Zerbi et al. 2014). Interestingly, vascular health also benefited from Fortasyn, 
as shown by increases in cerebral blood flow (CBF) after treatment. This finding suggests that this 
specific combination of dietary components may also improve the impairments associated with 
cerebrovascular diseases (CVD) such as stroke. Recently, we demonstrated the therapeutic potential 
of the above mentioned multinutrient intervention on ischemic stroke in male C57Bl/6 mice that 
received a focal ischemic stroke lesion (Wiesmann et al. 2017). In these male mice, treatment with 
Fortasyn improved stroke-induced impairments in functional and structural connectivity, cerebral 
blood flow and motor function and reduced neuroinflammation. This suggested that this 
multinutrient intervention may indeed serve as a promising treatment for ischemic stroke patients. 
However, care has to be taken in generalizing results obtained in males to female subjects, as it is 
known that responses to treatments can differ between sexes (Soldin & Mattison 2009).  
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Due to the genetic and biological differences between males and females, stroke impacts 
women very differently from males (Haast et al. 2012). In general, women experience more severe 
strokes than men. These severe stroke events mostly occur after menopause, suggestive of a 
protective role of estrogens (Liu et al. 2010). Even though traditionally stroke is mostly associated 
with older age, the number of young adults that experience a stroke event is rising (Kissela et al. 
2012). In premenopausal women, stroke risk is increased with for example pregnancy, a history of 
migraines and the use of hormonal contraception (Ekker et al. 2016). Personalized treatment 
strategies that can address stroke both in elderly and young women are therefore required. 
In the current study, we aimed to investigate the therapeutic potential of the Fortasyn diet 
in female stroke mice. We used the same experimental set-up as the previous performed study in 
male C57Bl/6 mice (Wiesmann et al. 2017). In short, we induced a focal ischemic stroke in 3-4 month 
old C57Bl/6 female mice by transiently occluding the middle cerebral artery (tMCAo) for 30 minutes 
and subsequently feeding them either the Fortasyn diet or an isocaloric Control diet. Using state-of-
the-art imaging techniques and behavioral tasks, we then investigated the therapeutic effect of the 
multinutrient intervention on brain structure and function, cerebral blood flow, behavior and motor 
skills. Gathering more knowledge on the effect of this dietary treatment on stroke in female mice 
will help with the development of gender-specific treatment regimens for CVD. 
 
Material and methods 
Animals  
A randomized double-blind controlled study using 24 female C57BL/6JRj mice (Harlan Laboratories 
Inc., Horst, the Netherlands; 2-3 months old) was conducted at the preclinical imaging center 
(PRIME) of the Radboud university medical center (Radboudumc) (Nijmegen, the Netherlands). 
Before tMCAo, the animals were group-housed (four animals per cage) in enriched, individually 
ventilated cages. Standard food pellets (Ssniff rm/h V1534-000, Bio Services, Uden, The Netherlands) 
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and autoclaved water were available ad libitum. In the room where the mice were kept, there was 
an artificial 12 hour light-dark cycle (lights on at 7 a.m.), humidity control and background music. 
Room temperature was kept constant at 21 ± 1°C. After tMCAo, the mice were housed separately to 
monitor intake of the experimental diets by each individual mouse. Experiments were performed 
according to Dutch federal regulations for animal protection and the European Union Directive of 22 
September 2010 (2010/63/EU). They were approved and pre-registered by the Animal Ethics 
Committee (called the Dierexperimentencommissie or DEC, RU-DEC 2014-171) of the 
Radboudumc (Nijmegen, The Netherlands). Furthermore, our experiments were performed 
according to the (updated) recommendations made by the Stroke Therapy Academic Industry 
Roundtable (STAIR) for the preclinical development of therapies for ischemic stroke (Fisher et al. 
2009, Stroke Therapy Academic Industry et al. 1999) and ARRIVE guidelines (Kilkenny et al. 2010). All 
applicable international, national, and institutional guidelines for the care and use of animals were 
followed. Our study was also in concurrence with the European regulations on ethics and 
responsible conduct regarding scientific communication. All behavioural and MRI experiments were 
performed in the Preclinical Imaging Centre (PRIME) of the Radboudumc between 8 a.m. and 6 p.m.. 
 
Transient Middle Cerebral Artery Occlusion (tMCAo)  
At 3-4 months of age, all mice underwent transient (30 minutes) occlusion of the right middle 
cerebral artery (tMCAo), thus mimicking one of the most common types of ischemic stroke in 
patients (Endres & Dirnagl 2002, Engel et al. 2011). The intraluminal occlusion model was performed 
as described elsewhere with minor modifications (Engel et al. 2011, Zinnhardt et al. 2015). To ensure 
comparability to our previous study (Wiesmann et al. 2017), the exact same procedures were 
followed and all surgeries were performed by the same experienced researcher that performed the 
surgeries on the male mice (co-author D.R.). In short, mice were anesthetized with 1.5% isoflurane 
(Abbott Animal Health, Abbott Park, IL, USA) in a 2:1 air and oxygen mixture and were kept under 
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anesthesia during the total time of the surgery. Next, a 7-0 monofilament (tip diameter 190 to 200 
μm, coating length 2 to 3 mm, 70SPRePK5, Doccol Corp., Sharon, MA, USA) was inserted in the right 
common carotid artery and positioned at the point where the middle cerebral artery branches out. A 
Laser Doppler probe (moorVMS-LDF2, Moor Instruments, UK) placed on the skull of the mice 
monitored CBF to assess the efficacy of the occlusion (≥80% loss of CBF). The middle cerebral artery 
was occluded for 30 minutes before retracting the filament allowing for reperfusion. After surgery, 
mice were carefully monitored to assess pain or other discomforts. Mice were weighed at least once 
a week. Exclusion criteria were decreased motor activity (<50% of the baseline measurements 
combined from the baseline values of each behavioral test) or extreme weight loss (>20% within 
three consecutive days). Lesion size was comparable in all animals and no dietary effect on lesion 
size could be detected as measured with a T2-weighted RARE sequence (data not shown). None of 
the mice died during or after tMCAo or reached the aforementioned exclusion criteria.  
 
Group allocation and diets 
Immediately after tMCAo, using a random sequence generator mice were randomly divided in two 
experimental groups, with one group being fed the Fortasyn diet (n=12) and the other group 
receiving an isocaloric Control diet (n=12). Group sizes were calculated based on the effect sizes 
(Type I error: 0.05, statistical power: 0.80), exclusion and mortality rates determined in our previous 
study (Wiesmann et al. 2017).  
Both the Fortasyn and the Control diet were based on AIN-93M (Reeves et al. 1993) with 5% 
fat, but differed with respect to their fatty acid composition and some additional nutrients. The 
Fortasyn diet contained 0.1% coconut oil, 1.9% corn oil and 3.0% fish oil, while the Control diet 
contained 1.9% soy oil, 0.9% coconut oil and 2.2% corn oil. Furthermore, the Fortasyn diet contained 
a specific multi-nutrient composition comprising uridine, omega-3 PUFAs, choline, B vitamins, 
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phospholipids and antioxidants (the specific composition is specified in (Wiesmann et al. 2017). Both 
diets were manufactured and pelleted by Ssniff (Soest, Germany) and stored at −20°C unƟl use. In 
the current study, the same batches of the diets as given to the mice in our previous study 
(Wiesmann et al. 2017) were used. Food intake was measured two times a week to calculate the 
average daily food intake per mouse. 
 
Behavior, cognition, and motor tasks  
All imaging and behavioral procedures and all data analyses were performed by researchers that 
were blinded to the treatment conditions. One mouse of the Fortasyn group was excluded from all 
of the experiments described below due to an enlarged kidney, leaving n=12 in the Control group 
and n=11 in the Fortasyn group. During the behavioral training/ acclimatization before the tMCAo all 
mice were trained on, and acclimatized to the testing equipment of both the grip strength test and 
the pole test. Resembling the actual experimental post-stroke situation all mice performed before 
the tMCAo only five consecutive trials for the grip strength test (5 for trapeze/ forepaws + 5 for grid/ 
all four paws) and also five consecutive trials for the pole test. The design of this study is illustrated 
in Figure 1. 
 
Open field 
Locomotion and explorative behavior were evaluated for 10 minutes in a square open field (45 x 45 x 
30 cm) prior to the tMCAo and diet switch (pre-stroke) and 3 and 21 days post-stroke as previously 
described. Using EthoVision XT10.1 (Noldus, Wageningen, The Netherlands), locomotion was 
automatically recorded. The floor of the arena was divided into center, periphery, and corners. The 
frequency of entering these zones was measured automatically. In addition, exploratory behavior 
was manually scored (walking, sitting, wall leaning, rearing and grooming) and analyzed as 
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previously described (Streijger et al. 2005). One mouse of the Fortasyn group was considered an 
outlier in the baseline measurements (i.e. hyperactive mouse) and was therefore excluded from the 
open field analyses. 
 
Grip strength test 
The grip strength test was performed prior to the tMCAo and diet switch (pre-stroke) and 14 and 27 
days post-stroke using a grip strength meter (Grip-Strength Meter, 47200, Ugo Basile, Italy) as 
previously described (Wiesmann et al. 2017). Muscle strength in the forelimbs (trapeze) and in all 
four limbs (grid) was determined. Trials were the mouse grasped the trapeze with one forelimb or 
grasped the grid with less than four limbs were excluded from the analyses. One mouse of the 
Fortasyn group was excluded from the analyses as pre-stroke it did not demonstrate a trapeze pull 
with both forelimbs. For both the trapeze and the grid, the maximum value of the peak force (in gf) 
was averaged per experimental group. 
 
Pole test 
The pole test was performed prior to the tMCAo and diet switch (pre-stroke) and 15 days post-
stroke as previously described (Wiesmann et al. 2017). The time needed to turn completely 
downward was measured manually, while the time to reach the floor was determined with 
EthoVision XT10.1 (Noldus, Wageningen, The Netherlands) and used to determine downward 
velocity (cm/s). The first trial of each pole test was excluded from the statistical analyses 
(acclimatization). Furthermore, trials where a mouse was turning on the pole before being released 
by the researcher were excluded and each mouse had to have at least three successful trials. Based 
on these criteria, three mice of the Control group and one mouse of the Fortasyn group were 
excluded from the pole test analyses. Furthermore, the turning time of four additional mice (2 of the 
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Control group and 2 of the Fortasyn group) could not be determined (e.g. the mouse walked over 
the top of the pole). These four mice were included in the downward velocity analyses. 
 
Prepulse inhibition (PPI) 
To examine sensorimotor integration, PPI was examined 16 days after stroke induction as previously 
described (Janssen et al. 2015). The startle reactivity of the mice was measured in the SR-LAB startle 
response system (San Diego Instruments, San Diego, CA, USA). PPI of the mouse was calculated 
during the second block of startle pulses (PPI (%) = 100x (response to startle pulse – response to 
startle pulse after a prepulse) / response to startle pulse). Furthermore, habituation to 120 dB startle 
pulses (given without prepulses) was examined by comparing the responses to startle pulses (in 
arbitrary units) of block 1 to block 3 (Streijger et al. 2005). Two mice of the Control group were 
considered statistical outliers (i.e. high response) in the no stimulus and 120dB startle pulse trials 
respectively and were therefore excluded from the PPI analyses. 
 
Novel object recognition test (ORT) 
All mice performed the ORT to measure short term memory 22 days (first acquisition day; 30 min 
delay) and 23 (second acquisition day; 60 min delay) days post-stroke as previously described 
(supplemental (Wiesmann et al. 2017). Using EthoVision XT10.1 (Noldus, Wageningen, The 
Netherlands), a recognition index (i.e. the time spent examining the novel object (N) minus the time 
spent examining the familiar object (F) in the test trial) was determined to assess recognition 
memory. Mice were excluded from the analyses when they either demonstrated a preference for 
one of the objects in the familiarization trials (>75% of time spend on one object) or did not explore 
either N or F in the test trial. One mouse of the Fortasyn group was considered an outlier in the 
baseline measurements (i.e. hyperactive mouse) and was therefore excluded from the ORT analyses. 
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MRI protocol  
MRI measurements were performed at 7 and 35 days post-stroke on a 11.7 T BioSpec Avance III 
small animal MR system (Bruker BioSpin, Ettlingen, Germany) operating on Paravision 6.0.1 software 
platform (Bruker, Karlsruhe, Germany) as previously described (Wiesmann et al. 2017, Zerbi et al. 
2014). In short, mice were anesthetized with isoflurane (Abbott Animal Health; 3.5% for induction 
and 1.8% for maintenance) in a 2:1 oxygen and N2O mixture and placed in a stereotactic holder. 
Body temperature was maintained at 37˚C and respiration was monitored. Mice were excluded from 
MRI analyses if their scans showed motion and/or echo planar imaging artifacts. Supplementary 
table 1 contains a list of parameters used in each MRI scan. 
 
Cerebral blood flow (CBF) 
To assess CBF, MR perfusion data were acquired under resting conditions using a flow-sensitive 
alternating inversion recovery (FAIR) technique as previously described (Wiesmann et al. 2017, Zerbi 
et al. 2014). In short, three regions of interest (ROI; cerebral cortex, hippocampus, and thalamus 
according to the atlas of Paxinos and Franklin (Paxinos & Franklin 2008)) were analyzed by two 
researchers that were blinded to the treatment conditions. CBF was then analyzed for each ROI in 
both the unaffected (contralateral/ left) and affected (ipsilateral/ right) hemisphere separately for 
each dietary group. The loss of CBF in the affected ROI was calculated as the difference in CBF 
between right and left hemispheric ROI relative to left hemispheric ROI. One mouse of the Control 
group and also one mouse of the Fortasyn group were excluded from analysis. 
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Diffusion tensor imaging (DTI) 
To assess the integrity of white matter (WM) and grey matter (GM), DTI was performed as 
previously described (Zerbi et al. 2014, Wiesmann et al. 2017). Mean water diffusivity (MD) and 
fractional anisotropy (FA) were derived from the tensor estimation following a protocol as described 
elsewhere (Zerbi et al. 2013). MD is considered an inverse measure of membrane density and is 
sensitive to changes in GM, while FA is an estimate of myelination and fiber density in WM (Le Bihan 
et al. 2001, Alexander et al. 2011, Feldman et al. 2010). MD and FA values were measured in several 
WM and GM areas that were manually selected based on an anatomical atlas (Paxinos & Franklin 
2008). No mice were excluded from analysis. 
 
Resting state functional MRI (rsfMRI) 
To assess patterns of functional connectivity, rsfMRI was determined as previously described 
(Wiesmann et al. 2017), see the supplementary material for a detailed description. Based on a 
previous functional connectivity study in mice (Jonckers et al. 2011) seven brain areas (bilateral) 
were selected for analysis. These areas were: the dorsal hippocampus, the ventral hippocampus, the 
auditory cortex, the motor cortex, the somatosensory cortex and the visual cortex. Three mice of the 
Control group and also three mice of the Fortasyn group were excluded from analysis. 
 
Immunohistochemistry 
Immediately following the MRI measurements performed 35 days after the stroke, the mice were 
sacrificed by transcardial perfusion using 4% paraformaldehyde (PFA) solution as previously 
described (Wiesmann et al. 2017). The brains were collected and separated into two parts. The 
frontal part of the brain (Bregma: -0.10 to 0.98) was post-fixed in 4% PFA, embedded in paraffin and 
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sliced into 5 µm sections. To measure presynaptic density, a staining for synaptophysin (SYN) was 
performed using monoclonal rabbit anti-synaptophysin clone EP1098Y (1:250; Abcam Inc., 
Cambridge, UK). The secondary antibody used was donkey anti-rabbit biotin (1:200; Jackson 
ImmunoResearch). Quantification of selected stained sections (Bregma: 0.02 to 0.62) was performed 
as previously described (Wiesmann et al. 2017). 
After a 24 hour incubation in a 30% sucrose solution, the other part of the brain (Bregma: -
0.7 to -4.36) was cut in 30 μm frontal sections using a sliding microtome (Microm HC 440, Walldorf, 
Germany) equipped with an object table for freeze-sectioning at -60°C. These free-floating sections 
were used to assess a) vascular integrity, measured with an antibody against glucose transporter-1 
(GLUT-1), b) neuroinflammation measured with an antibody against ionized calcium-binding adapter 
molecule 1 (IBA-1) and c) immature neurons (i.e. neurogenesis) measured with an antibody against 
doublecortin (DCX). For GLUT-1, a polyclonal rabbit anti-GLUT-1 primary antibody (1:80.000, 
Chemicon AB 1340, Chemicon International, Inc., Temecula, CA, USA) and a donkey anti-rabbit biotin 
secondary antibody (1:1500 Jackson ImmunoResearch, West Grove,PA, USA) was used. The primary 
antibodies used for IBA-1 and DCX were: polyclonal goat anti-IBA-1 (1:3000; Abcam) and polyclonal 
goat anti-DCX (1:8000; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). For both these proteins, 
donkey anti-goat biotin (1:1500; Jackson ImmunoResearch, West Grove, PA, USA) was used as a 
secondary antibody. Quantification of selected stained sections (Bregma: -1.46 to -2.30) was 
performed as previously described (Wiesmann et al. 2017). In short, the percentage of stained area 
(relative to unstained tissue) was determined using ImageJ software (National Institute of Health, 
Bethesda, MD, USA). Additionally, the number of DCX+ and IBA1+ cells and the number of GLUT-1+ 
blood vessels was manually counted in selected brain areas. All mice were included for all IHC 
procedures. 
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Statistical analysis 
For the statistical analysis of outliers and data, IBM SPSS 22 software (IBM Corporation, New York, 
NY, USA) was used. A multivariate ANOVA, univariate ANOVA or repeated measures ANOVA with 
Bonferroni corrections was conducted with between-group-factor diet and, if necessary, time and 
left-to-right-hemisphere-differences to analyze possible differences. Statistical significance was set 
at p<0.05, with p<0.08 considered a trend. Degrees of freedoms, F-values and p-values are given for 
each statistical analysis. All data are expressed as mean ± SEM.  
 
Results  
Body weight, diet intake, and estrous cycle 
To assess the well-being of the mice and monitor intake of the diets, body weight and diet intake 
were measured every week. Before stroke and subsequent diet switch, the average body weight of 
the mice that were randomly allocated to the Control diet group (21.3 ± 0.30 gr) was lower 
(F(1,21=4.7, p=0.042) than the body weight of the mice that were going to receive the Fortasyn diet 
(22.2 ± 0.28 gr; data not shown). To correct for this baseline difference, body weight differences 
after stroke and diet switch were all determined relative to pre-stroke weight (Supplementary Figure 
1A). Compared to baseline, the body weight of the mice decreased in the first week after stroke 
induction and diet switch (-16.1 ± 1.6%; F(1,21)=108.4, p<0.001). In the next two weeks, body weight 
of all mice increased with 9.22 ± 0.87 % (F(1,21)=113.5, p<0.001) relative to their weight in the first 
week after stroke and diet switch. In weeks 3 to 5 after the stroke, the body weight of all mice 
stabilized. Five weeks after the stroke and diet switch, body weight was 5.89 ± 1.3% lower than pre-
stroke body weight (F(1,21)=19.9, p<0.001). There was no diet effect on body weight. 
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Food intake was monitored after stroke and diet switch (Supplementary Figure 1B). In the 
first week after stroke and diet switch, mice on Fortasyn diet had a higher average daily food intake 
than the mice on control diet (3.14 ± 0.09 vs. 2.52 ± 0.08 gr/day; F(1,21)=5.3, p=0.032). Average daily 
food intake of both diet groups increased in the following week (F(1,21)=16.4, p=0.001), followed by 
a decrease in week 3 (F(1,21)=21.4, p<0.001). In weeks 3 to 5 after the stroke, average daily food 
intake of all mice stabilized. There were no differences in average daily food intake between Control 
diet and Fortasyn diet after the first week.  
35 days after the stroke the stage of the estrous cycle of each individual mouse was 
evaluated by visual observation based on (Byers et al. 2012). A digital image of each mouse was 
taken. Each experimental mouse was in the diestrus stage of the estrous cycle. 
 
Behavior, cognition and motor tasks  
Open field 
To measure activity, anxiety and explorative behavior, a 10 minute open field test was performed 
before stroke (pre-stroke baseline) and 3 and 21 days after the stroke and subsequent diet switch 
(Figure 2). Compared to baseline, mice on both diets moved a shorter distance 3 days after stroke 
(Figure 2A: F(1,20)=46.8, p<0.001) and had a lower velocity (F(1,20)=46.7, p<0.001; data not shown). 
Both parameters remained decreased 21 days after the stroke (distance: F(1,20)=0.920, p=0.349; 
velocity: F(1,20)=0.924, p=0.348). There was no diet effect on these parameters at 3 or 21 days after 
the stroke.  
The frequency of performing different types of (exploratory) behavior was manually scored 
(Figure 2B). Three days after the stroke and subsequent diet switch, the frequencies of walking 
(F(1,20)=23.0, p<0.001), wall leaning (F(1,20)=33.2, p<0.001; data not shown) and rearing 
(F(1,20)=27.1, p<0.001) decreased versus pre-stroke, while the frequency of sitting increased 
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(F(1,20)=96.3, p<0.001). Grooming frequency was initially unchanged (F(1,20)=2.59, p=0.123; data 
not shown), but decreased from 3 to 21 days after stroke (F(1,20)=5.66, p=0.029; data not shown). 
While between 3 and 21 days after stroke there was no change in sitting frequency (F(1,20)=1.11, 
p=0.305) or wall leaning frequency (F(1,20)=0.011, p=0.918; data not shown), walking frequency 
(F(1,20)=6.48, p=0.019) and rearing frequency (F(1,20)=40.0, p<0.001) decreased further. Three days 
after stroke and diet switch, mice on Fortasyn diet reared more frequent than mice on control diet 
(F(1,20)=7.1, p=0.015). There were no other effects of diet within these parameters. 
To assess anxiety and exploration, the position of the mice in the open field (center, corners, 
periphery) was determined (Figure 2C and 2D). Three days after the stroke, all mice visited the 
corners (F(1,20)=13.0, p=0.002), periphery (F(1,20)=26.0, p<0.001) and center (F(1,20)=19.1, 
p<0.001) of the open field less frequently than before the stroke (Figure 2C). Time spent in the 
center and periphery decreased (Figure 2D: F(1,20)=7.33, p=0.014 and F(1,20)=12.9, p=0.002 
respectively) for all mice compared to pre-stroke (while time spent in the corners increased 
(F(1,20)=20.7, p<0.001). Three weeks (21 days) after stroke, the number of visits to the center 
decreased further (Figure 2C: F(1,20)=6.4, p=0.020). There was no change in the number of visits to 
the corners (F(1,20)=0.10, p= 0.920) or periphery (F(1,20)=1.22, p=0.282) compared to 3 days after 
the stroke. The time spent in the corners did increase further for all mice (Figure 2D: F(1,20)=11.7, 
p=0.003) compared to 3 days after stroke, while time spent in the periphery decreased further 
(F(1,20)=8.49, p=0.009). Time spent in the center slightly tended to decrease (F(1,20)=3.56, 
p=0.074). There was no effect of diet on the positions within the open field at either time point after 
stroke. Before stroke induction, the mice that would receive Fortasyn spend less time in the corners 
than the mice that would receive Control diet (Figure 2D: F(1,20)=4.57, p=0.045).  
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Grip strength test 
The grip strength of the mice was tested before stroke induction (pre-stroke baseline) and 14 and 27 
days after stroke and subsequent diet switch (Figure 3A). Mice had to repeatedly pull either a 
trapeze with their forepaws or a grid with all four paws and the maximum grip strength (in gram-
force) was recorded. Two weeks after the stroke, maximum limb strength on the grid of all mice was 
lower than at baseline (F(1,20)=7.71, p=0.012), while maximum strength on the trapeze was 
unaltered (F(1,20)=0.977, p=0.335). There was no change in strength when comparing 14 days and 
27 days after the stroke (trapeze: F(1,20)=0.04, p=0.851; grid: F(1,20)=0.71, p=0.411) nor was there 
any diet effect. 
 
Pole test 
Motor coordination was determined 15 days after the stroke and subsequent diet switch (Figure 3B). 
Mice were repeatedly placed on a pole facing upwards and the time needed to turn around its body 
axis and the speed of the mouse while descending the pole were measured. Diet had no effect on 
either parameter.  
 
Prepulse inhibition (PPI) 
To assess sensorimotor integration, a PPI test with 4 different, randomly administered prepulses 
(PP2, PP4, PP8 and PP16) was performed 16 days after stroke and subsequent diet switch (Figure 3C 
and 3D). In this test, mice that received the Fortasyn diet tended to have a higher PPI than Control 
animals when a prepulse that was 4dB louder than background noise was given (Figure 3C: PP4: 40.7 
± 5.0% and 23.2 ± 7.2% respectively; F(1,19)=4.1, p=0.056). There was no other diet effect on PPI.  
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Fortasyn mice, but not Control mice (F(1,9)=0.55, p=0.477), habituated to the 120 dB pulses, 
as demonstrated by a reduction in the startle response triggered by these pulses from the beginning 
(12.5 ± 1.4) to the end (9.9 ± 0.9) of the test (Figure 3D: F(1,10)=5.5, p=0.04). 
 
Novel object recognition test 
To assess cognitive function, 22 and 23 days after stroke induction and diet switch a novel object 
recognition test was performed with a 30 minute or 60 minute intertrial interval respectively. There 
was no effect of diet on recognition memory (data not shown). 
 
MRI measurements 
Cerebral blood flow (CBF) 
To assess stroke and diet effects on brain perfusion, CBF was measured in three brain regions (in 
both left and right hemisphere) 7 and 35 days after the stroke and subsequent diet switch (Figure 4). 
Seven days after the stroke, CBF in the right cortex (Control: F(1,20)=4.4, p=0.050; Fortasyn: 
F(1,18)=15.6, p=0.001), right hippocampus (Control: F(1,20)=43.2, p<0.001; Fortasyn: F(1,18)=83.3, 
p<0.001), and right thalamus (Fortasyn: F(1,18)=11.5, p=0.003) was lower than in the corresponding 
left ROI (Figure 4A). There was no difference between the diets at this time point.  
Thirty-five days post-stroke (Figure 4A), mice on both diets demonstrated lower CBF in the 
right hippocampus (Control: F(1,20)=30.4, p<0.001); Fortasyn: F(1,18)=34.5, p<0.001) compared to 
the left hippocampus. Additionally, mice on Fortasyn had a lower CBF in the right cortex 
(F(1,18)=4.9, p=0.041) and in the right thalamus (F(1,18)=8.4, p=0.010) compared to the 
corresponding left ROI. Fortasyn mice tended to have a higher CBF (243.8 ± 11.5) than Control mice 
(211.2 ± 11.0) in the left thalamus (F(1,19)=4.2, p=0.05). 
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 Over time (35 days vs. 7 days post-stroke), mice on Fortasyn diet showed an increase in CBF 
in the right hippocampus (F(1,9)=9.9, p=0.012) and in the right cortex (F(1,9)=4.2, p=0.072) (Figure 
4A). These effects were not seen in mice on Control diet. In both diet groups, the CBF difference 
between the right and left hippocampus, i.e. loss of CBF, decreased (Figure 4C: Control, F(1,10)=8.7, 
p=0.015; Fortasyn, F(1,9)=37.0, p<0.001) over time. A similar decrease over time was also revealed in 
the thalamus of Fortasyn mice (F(1,9)=17.2, p=0.002), but not significant in the cortex of Control 
mice (F(1,10)=3.8, p=0.080).  
 
Diffusion tensor imaging (DTI) 
To assess brain integrity, quantitative assessment of diffusion tensor derived indices (fractional 
anisotropy, FA, Figure 5A; and mean diffusivity, MD, Figure 5B) was performed for nine white and 
gray matter regions 7 and 35 days after stroke and diet switch. 
 
Fractional anisotropy (FA) 
Seven days after stroke (Figure 5A), mice had a lower FA in the right caudate putamen and globus 
pallidus region (Cpu+GP; Control: F(1,22)=4.7, p=0.042; Fortasyn: F(1,20)=7.9, p=0.011), right 
hippocampus (HC; Control: F(1,22)=32.0, p<0.001; Fortasyn: F(1,20)=22.5, p<0.001), and right motor 
cortex (MC; Control: F(1,22)=4.9, p=0.038; Fortasyn: F(1,20)=5.0, p=0.038) than in the corresponding 
left ROI. Furthermore, at this time point Fortasyn mice tended to have a lower FA in the right visual 
cortex (VC; F(1,20)=4.3, p<0.051) compared to the left VC. At this time point, there were no effects 
of diet in either the left or right hemisphere. 
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Thirty-five days after the stroke (Figure 5A), mice had a lower FA in the right Cpu+GP 
(Control: F(1,22)=23.1, p<0.001; Fortasyn: F(1,20)=7.6, p=0.012) and right HC (Control: F(1,22)=37.6, 
p<0.001; Fortasyn: F(1,20)=5.5, p=0.030) than in the corresponding left ROI. Additionally, Control 
mice demonstrated a trend towards a lower FA in the right VC (F(1,22)=3.5, p=0.074) compared to 
left VC. At this time point after stroke, Fortasyn mice had a higher FA in the right Cpu+GP 
(F(1,21)=4.7, p=0.041) and in the right HC (F(1,21)=7.0, p=0.015) compared to Control mice. 
Furthermore, Fortasyn mice tended to have a higher FA in the left Cpu+GP (F(1,21)=3.5, p=0.077) 
and in the left HC (F(1,21)=3.4, p=0.079) than Control mice. There were no other differences 
between the right and left ROI in any of the other regions examined.  
We also investigated FA differences over time from 7 days to 35 days post-stroke (Figure 
5A). Control mice showed a decrease in FA over time in both the left (F(1,11)=39.6, p<.001) and right 
(F(1,11)=57.1, p<0.001) auditory cortex (AUC), left (F(1,11)=34.2, p<0.001) and right HC (F(1,11)=4.9, 
p=0.05), left MC (F(1,11)=4.1, p=0.068), the left (F(1,11)=16.9, p=0.002) and right somatosensory 
cortex (SSC; F(1,11)=11.5, p=0.006) and in the left (F(1,11)=10.0, p=0.009) and right VC (F(1,11)=12.5, 
p=0.005). Furthermore, Control mice demonstrated an increase in FA over time on both the left 
(F(1,11)=71.0, p<0.001) and right optic tract (OT; F(1,11)=40.8, p<0.001). Except for a tendency to an 
increase in FA in the left OT (F(1,10)=4.0, p=0.075), Fortasyn mice showed no FA changes over time. 
 
Mean diffusivity (MD) 
Seven days after stroke (Figure 5B), mice had a higher MD in the right OT (Control: F(1,22)=6.6, 
p=0.018; Fortasyn: F(1,20)=9.1, p=0.007) compared to the left OT. Furthermore, in Control mice, but 
not Fortasyn mice, MD in the right HC was higher than in the left HC (F(1,22)=5.0, p=0.036). There 
were no other left-right differences at this time point nor were there diet effects present. 
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Thirty-five days after the stroke (Figure 5B), MD of mice on Control diet was higher in the 
right AUC (F(1,22)=10.1, p=0.004), in the right HC (F(1,22)=4.4, p=0.047), and tended to be higher in 
the right Cpu+GP (F(1,22)=3.5, p=0.074) and compared to the corresponding left ROI. At this time 
point, mice on Fortasyn diet did not show any differences in MD between any of the left and right 
ROI. The Fortasyn mice did exhibit a decreased MD in the left HC (F(1,21)=5.0, p=0.037) and right OT 
(F(1,21)=4.8, p=0.040) compared to Control mice. 
We also investigated MD differences over time from 7 to 35 days post-stroke (Figure 5B). 
Control mice showed an increase in MD over time in the fornix (F(1,11)=8.5, p=0.014), left HC 
(F(1,11)=8.7, p=0.013), and both left (F(1,11)=24.8, p<0.001) and right OT (F(1,11)=9.6, p=0.010). 
Fortasyn mice only demonstrated an increase over time in the MD of the left OT (F(1,10)=14.4, 
p=0.003). 
 
Resting state fMRI (rsfMRI) 
To compare functional connectivity (FC) patterns, 7 and 35 days after stroke and diet switch total 
and partial rsfMRI correlations were determined for six brain regions. With total correlations, no 
significant diet nor time effects could be detected (data not shown). Partial correlation analysis 
(Figure 5C), accentuating the direct connectivity between two ROI while regressing the temporal 
BOLD signal from all other ROI, revealed significant time effects in mice on both diets (Figure 5E). 
Mice on Control diet demonstrated lower FC with time between left VC and left ventral HC 
(F(1,20)=7.6, p=0.012) and between right VC and right SSC (F(1,20)=4.9, p=0.039). Furthermore, in 
these Control mice FC between right dorsal HC and right ventral HC (F(1,20)=9.3, p=0.006), between 
right dorsal HC and left AUC (F(1,20)=5.1, p=0.035), and between left MC and right MC (F(1,20)=12.8, 
p=0.002) was increased over time. On Fortasyn diet, FC was decreased with time between left SSC 
and left ventral HC (F(1,18)=15.1, p=0.001) and between right SSC and right ventral HC (F(1,18)=5.0, 
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p=0.039). Fortasyn mice had a higher FC between left and right MC (F(1,18)=6.2, p=0.023), between 
left dorsal HC and left MC (F(1,18)=5.4, p=0.031), and between left AUC and right MC (F(1,18)=5.0, 
p=0.039) with time. Overall, FC showed a similar amount of increases and decreases with time in 
both diets. Fortasyn mice did show a higher FC between right AUC and left MC (F(1,15)=17.2, 
p=0.001) than Control mice 35 days after stroke and diet switch (Figure 5D). 
 
Immunohistochemistry 
After sacrifice of the mice, immunohistochemical stainings were performed on selected brain areas 
to assess neurogenesis (DCX), vascular density (GLUT-1), neuroinflammation (IBA-1) and presynaptic 
density (SYN). No left-right differences were detected in any of the stainings (Figure 6).  
Compared to Control mice, Fortasyn mice had a larger DCX+ area in the subventricular zone 
(Figure 6A: F(1,42)=4.1, p=0.050) while the number of DCX+ neurons in the hippocampus did not 
differ (data not shown). Fortasyn fed mice had both a larger relative IBA-1+ area (Figure 6E: 
F(1,42)=6.1, p=0.018) and more IBA-1+ cells than Control fed mice (Figure 6D: F(1,42)=4.2, p=0.046) 
in the cortex. In the hippocampus and thalamus, no diet effects on these parameters were detected 
(data not shown). In the hippocampus, Fortasyn mice furthermore exhibited a lowered vascular 
density (i.e. number of Glut-1+ vessels) compared to Control fed mice (Figure 6H: F(1,42)=6.5, 
p=0.014). No diet effects were found for the number of Glut-1+ vessels in the cortex and thalamus or 
the relative Glut-1+ area in any of the assessed ROI (data not shown). Finally, relative SYN+ area did 
not differ between the diet groups (data not shown). 
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Discussion 
In search for much-needed novel therapies for stroke, interventions with dietary components 
appear promising (Aquilani et al. 2011, Belayev et al. 2011, Schwarzkopf et al. 2015). Indeed, 
previously we determined that a multinutrient intervention (Fortasyn) first developed for use in 
early AD could improve brain perfusion, brain connectivity and motor function after the induction of 
a transient experimental focal ischemic stroke in male C57Bl/6 mice (Wiesmann et al. 2017). As it 
may be expected that female mice respond differently to treatment than males (Soldin & Mattison 
2009), in the current study we further examined the therapeutic potential of this multinutrient 
intervention in female mice. As far as we know, we are the first to treat stroke females with 
Fortasyn. In fact, only a small percentage of preclinical studies investigating mechanisms or 
interventions of stroke have been performed using female rodents (Beery & Zucker 2011) and, with 
few exceptions (e.g. (Janickova et al. 2015, Broersen et al. 2013)), most of the preclinical studies 
tested the efficacy of Fortasyn in males (Cansev et al. 2015, de Wilde et al. 2011, Jansen et al. 2013, 
Jansen et al. 2014, Wiesmann et al. 2013, Wiesmann et al. 2016, Wiesmann et al. 2017, Zerbi et al. 
2014). In our stroke females, the induction of a focal ischemic lesion by tMCAo impaired the activity 
and motor skills of the mice and affected the perfusion, integrity and connectivity of the brain. The 
effects of Fortasyn on stroke-induced impairments in the females were diverse. Fortasyn improved 
brain integrity and neurogenesis and, to some extent, CBF and brain connectivity, but did not affect 
deficits in activity or motor skills. Increased inflammation and decreased vascular density in the 
Fortasyn-treated stroke females need further study for a proper interpretation. Sensorimotor 
integration, as assessed in the PPI test, however did seem to benefit from Fortasyn in these females, 
while no effects were previously observed in males (Wiesmann et al. 2017).  
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Cerebral hemodynamics 
In the male stroke mice, Fortasyn improved cerebral perfusion (Wiesmann et al. 2017), which is in 
line with the beneficial effects of Fortasyn on CBF seen in our previous studies using mouse models 
for AD (Wiesmann et al. 2016, Zerbi et al. 2014). In line with the previous studies, Fortasyn did also 
increase CBF in the stroke females with time in individual brain areas such as the right cortex and 
right hippocampus. However, different from the Fortasyn stroke males (Wiesmann et al. 2017) left-
right differences in CBF in the female Fortasyn mice did not totally recover with time. Therefore, it 
seems as though the cerebral blood flow in stroked females did not benefit from Fortasyn to the 
same extent as it did in the male stroke mice and it remains to be investigated why the stroke 
females on Fortasyn did not show at least a similar recovery. Future studies should therefore 
investigate also the impact of such a multinutrient intervention on possible mechanisms (e.g. 
smooth muscle cell behavior) being involved in the cerebral vasoreactivity. 
 
Brain integrity, sensorimotor integration, and functional connectivity 
Stroke effects on WM and GM integrity are clearly present in the females. Indeed, these stroke 
effects seem more extensive than the stroke effects on brain integrity seen in the males (Wiesmann 
et al. 2017), i.e. a greater number of brain areas demonstrate ipsilateral WM and GM integrity 
impairments in the females. This finding seems in contrast to the well-known fact that specifically in 
women estrogens should be able to reduce stroke-induced brain damage (Liu et al. 2010). A study 
simultaneously examining stroke effects in both male and female mice may resolve this discrepancy.  
Fortasyn seems to inhibit the progressive impairment of WM and GM microstructure that 
was demonstrated in the female stroke mice fed the Control diet. Furthermore, in several brain 
areas, WM and GM integrity of the Fortasyn mice was higher than in the Control mice. These 
beneficial effects of Fortasyn are in line with previous studies testing the effect of (components of) 
this multinutrient intervention on brain integrity (Wiesmann et al. 2016, Jiang et al. 2016) and they 
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are furthermore supportive of the membrane synthesizing potential of this particular multinutrient 
intervention (van Wijk et al. 2014). Up to now, mechanisms are still unknown how tissue integrity 
could be influenced by dietary components like omega-3 fatty acids. Notably, investigating T2-values 
to detect changes in brain membrane composition, Hirashima et al. demonstrated in women with 
bipolar disorder that omega-3 fatty acid supplementation for 4 weeks lowered T2 values indicating a 
treatment-induced increase in membrane fluidity (Hirashima et al. 2004). This result could help us to 
understand the beneficial also treatment-induced effects on WM and GM microstructure being 
found in our study. As stroke-induced WM impairments can cause sensorimotor impairments (Wang 
et al. 2016), the improved performance in the PPI test by Fortasyn-treated mice may be linked to the 
rescue of WM integrity by this diet. Indeed, in mice treated with n-3 polyunsaturated fatty acids, 
improvements in WM integrity were positively correlated to sensorimotor performance in the 
cylinder test (Jiang et al. 2016). The beneficial effect of Fortasyn on sensorimotor integration in this 
study may be indicative of the efficacy of multinutrient interventions in psychiatric disorders with 
extensive sensorimotor impairments, such as schizophrenia and Gilles de la Tourette’s syndrome 
(Kohl et al. 2013, Geyer 2006).  
Our MRI data revealed that the enhancement of brain integrity by Fortasyn was 
accompanied by a Fortasyn-specific improvement of functional connectivity in stroke females; 
comparably to stroke males (Wiesmann et al. 2017), Fortasyn increased FC between the right AUC 
and the left MC. However, while the stroke males showed several beneficial effects of Fortasyn on 
FC, in the females this effect was limited to this one improved connection. An explanation for this 
modest effect of Fortasyn in the females may be that the duration of treatment (i.e. 35 days) was 
insufficient to elicit a substantial beneficial effect of Fortasyn on stroke-induced impairments of 
functional connectivity present in our stroke females. Indeed, previously when Fortasyn improved 
functional connectivity, treatment periods could last up to 16 months (Wiesmann et al. 2016). The 
relatively short duration of our treatment may also explain the lack of a (beneficial) effect of 
Fortasyn on the synaptic marker SYN in both female and male mice (Wiesmann et al. 2017). In 
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ApoE4 mice, levels of a postsynaptic marker, PSD-95, were unaffected with 10 months of treatment 
with Fortasyn diet, but finally increased after 16 months of treatment (Wiesmann et al. 2016). 
 
Neurogenesis and inflammation 
Stroke can trigger neurogenesis both in rodent and human brain (Lindvall & Kokaia 2015), 
presumably in an effort to repair the ischemic damage, but this neurogenesis is insufficient to induce 
lasting, functional recovery. While we did not investigate effect of tMCAo on neurogenesis, in the 
current study we did find that Fortasyn can enhance neurogenesis in both the ipsi- and contralateral 
subventricular zones. It seems that Fortasyn is capable of enhancing the production of novel cells 
after stroke, which is in line with the effect of Fortasyn on neurogenesis seen in the stroke males 
(Wiesmann et al. 2017) and in male APP/PS1 mice (Jansen et al. 2013). It remains to be investigated 
whether these novel cells can develop into mature and functional cells capable of repairing stroke 
damage.  
Functional integration of novel cells into damaged areas in part relies upon the presence of a 
beneficial inflammatory environment. An ischemic event in the brain triggers an immediate 
inflammatory response, with recruitment and activation of microglia particularly in the affected 
ischemic brain area (Taylor & Sansing 2013). In this study, there was no difference between the 
affected hemisphere and the unaffected hemisphere regarding Iba-1 expressing inflammatory cells, 
perhaps because the initial inflammatory response occurring immediately after stroke induction had 
already vanished 35 days after the stroke. However, compared to the mice fed the Control diet, the 
Fortasyn mice demonstrated more IBA-1+ cells in the cortex, suggesting that Fortasyn can modulate 
inflammation. As IBA-1 expressing microglia are capable of being both harmful and protective 
(Taylor & Sansing 2013), discovering the exact nature of a Fortasyn-induced inflammatory response 
in both females and males is necessary to establish if Fortasyn has a beneficial or detrimental effect 
on inflammation. 
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Motor function, behavior, and cognition 
tMCAo is known to result in impairments of motor skills and activity (Balkaya et al. 2013), and 
indeed the stroke females demonstrated functional impairments. Stroke males on the Fortasyn diet 
showed improvements in motor strength, motor coordination and activity compared to Control mice 
(Wiesmann et al. 2017), but none of these effects could be replicated in the stroke females. Three 
days after stroke induction, Fortasyn-fed females did demonstrate increased rearing frequency 
compared to Control females. Finally, the ORT revealed that Fortasyn did not affect cognition in the 
stroke females, probably because the ORT was measured from 22 to 24 days post-stroke. Another 
study demonstrated a significantly reduced preference at 7 and 14 days following stroke, but also 
normal values between 21 and 28 days post-stroke suggesting recovery of cognition after 3 to 4 
weeks (Wang et al. 2012). Therefore in future research, ORT or other cognition tests should be 
performed earlier after the induction of the experimental stroke to detect subtle deficits and dietary 
effects. Nevertheless, MCAo leads to a range of cognitive changes, relying upon gender, strain, and 
the occlusion time (Jiwa et al. 2010). Moreover, in some studies impaired learning with the MWM 
was found (Gibson & Murphy 2004), while other studies could not replicate this result (Bouët et al. 
2007) indicating possible differences in cerebral vasculature between murine strains. Thereby 
cognitive decline in patients is influenced by co-morbidities and pre-existing conditions that affect 
the entire brain (and pre-dispose stroke) and these conditions are hard to model in the otherwise 
healthy rodent with only a restricted unilateral injury. 
 
Conclusion 
As previously demonstrated, treatment with the Fortasyn multinutrient intervention has multiple 
beneficial effects on impairments seen in AD (van Wijk et al. 2014) and ischemic stroke (Wiesmann 
et al. 2017). In the current preclinical stroke study, as far as we know one of the first to use females, 
the beneficial effects of the Fortasyn diet were less pronounced compared to those found in male 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
mice (Wiesmann et al. 2017), perhaps because the stroke seemed to impact the females more 
severe than the males. This suggests that indeed, as previously observed (Soldin & Mattison 2009), 
the outcome of treatment in males and females can differ and emphasizes the necessity to include 
both sexes in preclinical studies, preferably simultaneously. Rodents like mice and especially the 
female mice may be affected by the dissimilar amount of phytoestrogens in the two diets. This 
difference may also explain that in this recent study less beneficial effects of the Fortasyn diet were 
found in female stroke mice than in male stroke mice compared to the Control diet. However, very 
small amounts of phytoestrogens are present in soy oil and even smaller amounts will be present in 
the control diet containing 3% soy oil which will in all probability not provide ample amounts to 
evoke a physiological response in mice. Nevertheless, in future research this should be taken in 
consideration when composing the diets. In our opinion, the fact that the effects of Fortasyn in the 
current study were diverse does not negate the efficacy of multinutrient intervention treatments in 
the recovery of female stroke patients. As discussed, stroke females may benefit from extended 
treatment durations. Furthermore, testing multinutrient interventions in female mice modeling the 
changes occurring with menopause, e.g. an ovariectomized female mouse (Diaz Brinton 2012), may 
be more appropriate to assess the effects of interventions in stroke females. In our opinion, these 
future studies, together with the current study, will help create effective dietary treatment regimens 
for CVD such as stroke in both females and males. Nevertheless, a longer multinutrient intervention 
period would possibly have a much stronger effect on cardio- and cerebrovascular health, and 
potentially have some benefit to prevent dementia via increasing cognitive reserve. Future studies 
should take this into account and study the effect of longer dietary treatments. Multinutrient 
interventions seem to be a beneficial add-on to the already existing ways of therapy (thrombolysis 
and/ or thrombectomy) to enhance recovery of (female) stroke patients. Therefore, future studies 
are needed to investigate the efficacy of the treatment combination of the traditional stroke 
therapies with such a multinutrient intervention. 
--Human subjects -- 
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Figure legends 
 
Figure 1. Study design. Before ischemic stroke induction (tMCAo on day 0), female C57Bl/6 mice 
were allowed to acclimatize after which they underwent several prestroke behavioral tests (baseline 
measurements). Immediately after stroke induction, the females were given either the Fortasyn 
multinutrient diet (n=11) or an isocaloric Control diet (n=12). After the stroke, several behavioral 
tasks were (again) performed. Furthermore, MRI scanning was performed twice after stroke 
induction. Ppi, prepulse inhibition; tMCAo, transient middle cerebral artery occlusion; ORT, novel 
object recognition test 
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Figure 2. Activity, anxiety and (explorative) behavior was measured in the open field pre-stroke 
(pre) and 3 days (3d) and 21 days (21d) after stroke induction and diet switch. (A) Compared to 
pre-stroke, 3 days after the stroke all mice moved less distance. The distance moved remained 
decreased 21 days after the stroke. (B) Compared to pre-stroke, the frequency of walking and 
rearing decreased 3 days after the stroke, while the frequency of sitting increased. Rearing 
frequency decreased further 21 days after stroke compared to 3 days after stroke. Mice fed the 
Fortasyn diet reared more frequently 3 days after the stroke induction and diet switch. (C) 
Compared to pre-stroke, the frequency of entering the center, corners and periphery decreased 3 
days after the stroke. (D) The time spend in the center and periphery decreased compared to pre-
stroke, while the time spend in the corners increased. The time spend in the periphery had 
decreased further 21 days after stroke induction and the time spend in the corners increased 
further. Values represent mean ± SEM. Control: n=12, Fortasyn: n=10. * p<0.05, ** p<0.01, *** 
p<0.001  
 
Figure 3. Motor strength (A), motor coordination (B) and sensorimotor integration of female 
stroke mice measured before (pre) and after (grip test: 14 and 27 days; pole test: 15 days; prepulse 
inhibition: 16 days) stroke induction and diet switch. (A) On the trapeze of the grip test (Control: 
n=12, Fortasyn: n=11) no differences over time or with diet were demonstrated. On the grid, stroke 
females had a decreased maximum strength 14 days after stroke induction. (B) In the pole test 
(Control: n=6, Fortasyn: n=8), diet did not affect rotation time of the females 15 days after stroke 
induction and diet switch. (C) Fortasyn stroke females (n=11) tended to have a higher PPI (%) than 
Control stroke females (n=10) when a prepulse of 4dB was given (PP4). There was no effect of diet 
with any of the other prepulses. (D) Fortasyn stroke females (n=11) habituated to the 120 dB startle 
pulses as demonstrated by a reduction in startle response from the beginning to the end of the PPI 
test. Values represent mean ± SEM. Abbreviations: g-f, gram-force; PP, prepulse (of either 2, 4, 8 or 
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16 dB above background noise); PPI, prepulse inhibition; a.u., arbitrary units. # p<0.08, * p<0.05, ** 
p<0.01. 
 
Figure 4 Cerebral blood flow (CBF) determined with flow-sensitive alternating inversion recovery 
(FAIR) MRI 7 and 35 days after stroke induction and diet switch in cortex, hippocampus and 
thalamus. (A) In general, at both time points CBF was lower in the right brain hemisphere, where the 
middle cerebral artery was occluded, than in the left brain hemisphere. Only in the cortex of female 
Control mice (35 days after stroke induction) and in the thalamus of female Control mice (7 and 35 
days after stroke induction) did CBF not differ between hemispheres. In the cortex and hippocampus 
of the Fortasyn females, CBF tended to increase with time. In the left thalamus, Fortasyn females 
tended to have a higher CBF than Control females. (B) Representative high-resolution voxel-wise 
analyzed CBF images at 7 and 35 after stroke induction and diet switch. (C) The CBF difference 
(Δ%CBF normalized to CBF in the left brain area) between the left and right cortex and between the 
left and right hippocampus decreased with time in female Control mice. In stroke females on 
Fortasyn diet, the CBF difference between the left and right hippocampus and the left and right 
thalamus decreased with time. Values represent mean ± SEM. Control: n=11, Fortasyn: n=10. # 
p<0.08, * p<0.05, ** p<0.01, *** p<0.001 
 
Figure 5. White matter (WM) and grey matter (GM) integrity as measured by quantitatively 
assessed diffusion tensor derived indices (A+B) and resting-state functional connectivity (FC) based 
on partial correlation analyses (C-E) measured 7 and 35 days after stroke induction and diet 
switch. (A) In several brain areas of both Control and Fortasyn stroke females, FA (a measure of WM 
integrity) was lower in the right hemisphere than in the left hemisphere. In the Control stroke 
females, FA became lower with time in the AUC, HC, SSC and VC. FA in the OT increased with time in 
both the Control and Fortasyn stroke females. Thirty-five days after stroke induction and diet switch, 
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the Fortasyn stroke females had an increased FA compared to Control stroke females in both the left 
and right HC and Cpu+GP. (B) In several brain areas of particularly Control stroke females, MD (a 
measure of GM integrity) was higher in the right hemisphere than in the left hemisphere. In the 
Control stroke females, MD became higher with time in the F, HC and OT. In the Fortasyn stroke 
females, MD became higher with time in the left OT. Thirty-five days after stroke induction and diet 
switch, the Fortasyn stroke females had a decreased MD compared to Control stroke females in the 
left HC and right OT. Abbreviations: FA= fractional anisotropy, MD=mean diffusivity, AUC=auditory 
cortex, CC=corpus callosum, F=fornix, HC=hippocampus, MC=motor cortex, OT=optic tract, 
SSC=somatosensory cortex, VC=visual cortex, Cpu+GP= caudate putamen+globus pallidus. Control: 
n=11, Fortasyn: n=10. Values represent mean ± SEM. # p<0.08, * p<0.05, ** p<0.01, *** p<0.001. (C-
E) Thirty-five days after tMCAo, the partial correlations demonstrated that Fortasyn stroke females 
had an increased FC between right AUC and left MC. No other diet effects were found. Over time, 
the same amount of FC improvements (+) and impairments (-) were found for Fortasyn and Control 
stroke females. Abbreviations: DH= dorsal hippocampus, VH=ventral hippocampus, AUC=auditory 
cortex, MC=motor cortex, SSC=somatosensory cortex, VC=visual cortex. Control: n=12, Fortasyn: 
n=11. Values in (C) represent mean z-scores. 
 
Figure 6. Neurogenesis (A-C), inflammation (D-G) and vascular density (H-J) markers were assessed 
in postmortem brains of the females that were sacrificed 35 days after stroke induction and diet 
switch. (A) The Fortasyn stroke females (n=11) had a larger DCX+ area in the SVZ than Control stroke 
females (n=12). (B) and (C) are representative images of the DCX staining in the SVZ of respectively 
Control and Fortasyn stroke females. The Fortasyn stroke females (n=11) had a higher number of 
IBA-1+ cells (D) and a larger IBA-1+ area (E) in the cortex than Control stroke females (n=12). (F) and 
(G) are representative images of the IBA-1 staining in the cortex of respectively Control and Fortasyn 
stroke females. (H) The Fortasyn stroke females (n=11) had a decreased number of GLUT-1+ cells 
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(per mm2) in the hippocampus compared to Control stroke females (n=12). (I) and (J) are 
representative images of the GLUT-1 staining in the hippocampus of respectively Control and 
Fortasyn stroke females. Values represent mean ± SEM. * p<0.05, ** p<0.01 
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